- Title
- Comprehensive quantitative proteomic profiling of the pharmacodynamic changes induced by MLN4924 in acute myeloid leukemia cells establishes rationale for its combination with azacitidine
- Creators
- Valeria Visconte - Cleveland ClinicSteffan T. Nawrocki - The University of Texas Health Science Center at San AntonioClaudia M. Espitia - The University of Texas Health Science Center at San AntonioKevin R. Kelly - USC Norris Comprehensive Cancer CenterAnthony Possemato - Cell Signaling TechnologySean A. Beausoleil - Cell Signaling TechnologyYingchun Han - Cleveland ClinicHetty E. Carraway - Cleveland ClinicAziz Nazha - Cleveland ClinicAnjali S. Advani - Cleveland ClinicJaroslaw P. Maciejewski - Cleveland ClinicMikkael A. Sekeres - Cleveland ClinicJennifer S. Carew - Cleveland Clinic
- Publication Details
- Leukemia, Vol.30(5), pp.1190-1194
- Academic Unit
- Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
- Language
- English
- Resource Type
- Journal article
- PMID
- 26369982
- PMCID
- PMC4792796
- Record Identifier
- 991031757327402976
Journal article
Comprehensive quantitative proteomic profiling of the pharmacodynamic changes induced by MLN4924 in acute myeloid leukemia cells establishes rationale for its combination with azacitidine
Leukemia, Vol.30(5), pp.1190-1194
2015-09-15
PMCID: PMC4792796
PMID: 26369982
Metrics
1 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Industry collaboration
- Domestic collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.25 Molecular & Cell Biology - Cancer, Autophagy & Apoptosis
- 1.25.782 Proteasome
- Web Of Science research areas
- Hematology
- Oncology
- ESI research areas
- Clinical Medicine
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites